Mice with a knockout of the GPX4 gene succumb to renal failure, and inhibitors of GPX4 have shown promise in enhancing the efficacy of treatments against drug-resistant, persistent cancer cells [44,45]. The gene discussed is GPX4; the disease is cancer.